New Zealand markets closed

GSK plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
41.22+0.31 (+0.77%)
As of 12:23PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 83.51B
Enterprise value 99.74B
Trailing P/E 13.70
Forward P/E 10.46
PEG ratio (5-yr expected) 1.10
Price/sales (ttm)2.23
Price/book (mrq)5.03
Enterprise value/revenue 3.29
Enterprise value/EBITDA 10.98

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 313.54%
S&P500 52-week change 321.08%
52-week high 343.84
52-week low 333.33
50-day moving average 341.82
200-day moving average 337.91

Share statistics

Avg vol (3-month) 33.49M
Avg vol (10-day) 32.99M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.91B
% held by insiders 10.06%
% held by institutions 114.85%
Shares short (15 Apr 2024) 47.35M
Short ratio (15 Apr 2024) 42.57
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.36%
Shares short (prior month 15 Mar 2024) 43.97M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 43.59%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 31.42%
5-year average dividend yield 44.97
Payout ratio 446.93%
Dividend date 311 Apr 2024
Ex-dividend date 422 Feb 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 16.25%
Operating margin (ttm)20.35%

Management effectiveness

Return on assets (ttm)8.81%
Return on equity (ttm)46.38%

Income statement

Revenue (ttm)30.33B
Revenue per share (ttm)14.97
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
EBITDA 10.3B
Net income avi to common (ttm)4.93B
Diluted EPS (ttm)2.99
Quarterly earnings growth (yoy)-76.60%

Balance sheet

Total cash (mrq)5.69B
Total cash per share (mrq)1.4
Total debt (mrq)18.02B
Total debt/equity (mrq)140.82%
Current ratio (mrq)0.88
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)6.77B
Levered free cash flow (ttm)3.56B